Krónikus mieloid leukémia (CML): vizsgálatok itt: Ausztrália
10 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Where
- Brisbane, North Adelaide
- Életkor
- 1 év to 18 év
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07354074 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Macquarie University, Melbourne, Nedlands, Randwick
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1/2. fázisTaking peopleA Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
- Where
- Adelaide, Clayton, Melbourne, Perth
- Életkor
- 18 év to 64 év
- People
- 330 worldwide
- Run by
- Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
See details and how to joinNCT06163430 · EU 2023-507677-18-00 - 2. fázisTaking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Kingswood, Melbourne N., Southport
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 3. fázisTaking peopleStudy of Olverembatinib (HQP1351) in Patients With CML-CP
- Where
- Adelaide, Campbelltown, Liverpool, Perth
- Életkor
- 18 év and over
- People
- 333 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06423911 · EU 2024-511495-32-00 - 1/2. fázisTaking peopleStudy to Evaluate the Safety and Tolerability of EP0042
- Where
- Perth
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Ellipses Pharma
See details and how to joinNCT04581512 · EU 2024-514588-24-00 - 1. fázisTaking peopleA Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Where
- Adelaide
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Enliven Therapeutics
See details and how to joinNCT05304377 · EU 2023-503335-18-00 - 1. fázisTaking peopleCombined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
- Where
- Sydney, Westmead
- Életkor
- 18 év and over
- People
- 12
- Run by
- Clinical Hub for Interventional Research (CHOIR)
See details and how to joinNCT05636514 - 1/2. fázisTaking peopleClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Albury, Fitzroy, Herston, Nedlands, Townsville
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00 - No phaseTaking peopleInternational Chronic Myeloid Leukemia Pediatric Study
- Where
- North Adelaide
- Életkor
- Up to 18 év
- People
- 750 worldwide
- Run by
- Poitiers University Hospital
See details and how to joinNCT01281735